ArticleJournal of translational medicine2020

Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting.

Nina Körber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.